Erratum
American Diabetes Association. Standards of medical care in diabetes—2012 (Position Statement). Diabetes Care 2012;35(Suppl. 1):S11–S63
In the print version of the article listed above, reference 79 is incorrectly cited in the following sentence appearing on page S20: “Many factors, including patient preferences, should be taken into account when developing a patient’s individualized goals (79).” Reference 89a (Ismail-Beigi F, Moghissi E, Tiktin M, Hirsch IB, Inzucchi SE, Genuth S. Individualizing glycemic targets in type 2 diabetes mellitus: implications of recent clinical trials. Ann Intern Med 2011;154:554–559) should have been cited in this sentence. Also, on page S21, reference 99 is incorrectly cited in the following sentence: “Meta-analyses (99) suggest that overall, each new class of noninsulin agents added to initial therapy lowers A1C around 0.9–1.1%.” Reference 98a (Bennett WL, Maruthur NM, Singh S, et al. Comparative effectiveness and safety of medications for type 2 diabetes: an update including new drugs and 2-drug combinations. Ann Intern Med 2011;154:602–613) should have been cited in this sentence. And on page S42, references 396 and 397 should have been cited in the sentence “Though scientific evidence continues to be limited, it is clear that early and ongoing attention be given to comprehensive and coordinated planning for seamless transition of all youth from pediatric to adult health care (336,337).” The online version reflects these changes.
- © 2012 by the American Diabetes Association.
